Frontline Treatment With Bendamustine in Combination With Rituximab in Adults Age 65 or Older With Chronic Lymphocytic Leukemia (CLL)

NCT00758693 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Funding was withdrawn due to insufficient accrual

Conditions

Chronic Lymphocytic Leukemia

Interventions

DRUG: Bendamustine
DRUG: Rituximab

Sponsor

University of Kentucky

Collaborators

[object Object]